Literature DB >> 10923074

Nuclear localization of E-cadherin expression in Merkel cell carcinoma.

A C Han1, A P Soler, C K Tang, K A Knudsen, H Salazar.   

Abstract

CONTEXT: Cadherins are cell-cell adhesion proteins that act as tumor suppressor genes and have a critical role in cell sorting and tissue formation during organogenesis. The pattern of cadherin expression constitutes a useful diagnostic and prognostic tool in the evaluation of tumors and for determining the histogenesis of tumor cells. We have previously characterized the cell types of several tumors based on the expression of individual cadherins.
OBJECTIVE: To investigate the expression of cadherins in Merkel cell carcinomas.
DESIGN: Paraffin immunohistochemical analysis of the 3 best-studied cadherins was performed on 35 cases of Merkel cell carcinoma.
RESULTS: E-cadherin was expressed in 34 (97%) of 35 Merkel cell carcinomas examined, N-cadherin was expressed in 22 (63%) of 35 cases, and P-cadherin was expressed in 15 (43%) of 35 cases. This frequency of cadherin expression was similar to a group of small cell and neuroendocrine tumors from other primary sites. Interestingly, the localization of E-cadherin expression was unique in Merkel cell carcinomas compared with other primary neuroendocrine tumors. Merkel cell carcinomas showed marked preference for nuclear versus membrane localization, whereas small cell tumors from other sites showed fewer cases of nuclear E-cadherin expression. The nuclear localization of E-cadherin did not correlate with cadherin-associated protein beta-catenin nuclear expression.
CONCLUSIONS: Our findings show that E-cadherin is the most frequently expressed cadherin in Merkel cell carcinoma, followed in frequency by N-cadherin then P-cadherin. The pattern of nuclear E-cadherin expression is more frequent for Merkel cell carcinoma than small cell tumors of other primary sites. These observations suggest that E-cadherin expression and function are altered in Merkel cell carcinoma, and this finding has potential use in the differential diagnosis of these tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923074     DOI: 10.5858/2000-124-1147-NLOECE

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  15 in total

1.  E-cadherin expression in transitional cell carcinomas.

Authors:  Eszter Székely; Virág Török; Tamás Székely; Péter Riesz; Imre Romics
Journal:  Pathol Oncol Res       Date:  2006-06-24       Impact factor: 3.201

Review 2.  E-cadherin's dark side: possible role in tumor progression.

Authors:  Fausto J Rodriguez; Laura J Lewis-Tuffin; Panos Z Anastasiadis
Journal:  Biochim Biophys Acta       Date:  2012-03-13

3.  Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray.

Authors:  Charles F Knapp; Zena Sayegh; Michael J Schell; Bhupendra Rawal; Tatiana Ochoa; Vernon K Sondak; Jane L Messina
Journal:  Am J Dermatopathol       Date:  2012-08       Impact factor: 1.533

4.  Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model.

Authors:  María Virtudes Céspedes; María Jesús Larriba; Miguel Angel Pavón; Patricia Alamo; Isolda Casanova; Matilde Parreño; Anna Feliu; Francesc Josep Sancho; Alberto Muñoz; Ramón Mangues
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

5.  Expression of adhesion molecules and cytokeratin 20 in merkel cell carcinomas.

Authors:  Yasushi Tanaka; Toshiaki Sano; Zhi Rong Qian; Mitsuyoshi Hirokawa
Journal:  Endocr Pathol       Date:  2004       Impact factor: 3.943

6.  Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer.

Authors:  Teresa Chiaverotti; Suzana S Couto; Annemarie Donjacour; Jian-Hua Mao; Hiroki Nagase; Robert D Cardiff; Gerald R Cunha; Allan Balmain
Journal:  Am J Pathol       Date:  2007-12-21       Impact factor: 4.307

7.  Evaluation of myosin VI, E-cadherin and beta-catenin immunostaining in renal cell carcinoma.

Authors:  Hanna Ronkainen; Saila Kauppila; Pasi Hirvikoski; Markku H Vaarala
Journal:  J Exp Clin Cancer Res       Date:  2010-01-14

8.  Increased expression of Dsg2 in malignant skin carcinomas: A tissue-microarray based study.

Authors:  Donna Brennan; Mÿ G Mahoney
Journal:  Cell Adh Migr       Date:  2009-04-04       Impact factor: 3.405

9.  Altered expression of β-catenin, E-cadherin, and E-cadherin promoter methylation in epithelial ovarian carcinoma.

Authors:  Rahul Bhagat; C S Premalata; V Shilpa; V R Pallavi; G Ramesh; C R Vijay; Lakshmi Krishnamoorthy
Journal:  Tumour Biol       Date:  2013-04-19

Review 10.  Protein mislocalization: mechanisms, functions and clinical applications in cancer.

Authors:  Xiaohong Wang; Shulin Li
Journal:  Biochim Biophys Acta       Date:  2014-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.